Quince Therapeutics, Inc. Common Stock (QNCX)

Typically moves ±12.77% on earnings
EARNINGS ANALYTICS
event_upcoming Next Earnings: 2026-08-12 HIGH CONFIDENCE
search

Since Feb 02, 2022, Quince Therapeutics, Inc. Common Stock (QNCX) has reported earnings 12 times. On average the shares move ±12.77% post-earnings, with a positive reaction 33.3% of the time. Its largest post-earnings gain was +18.89% (Nov 13, 2024) and its largest decline was -61.49% (Feb 12, 2026). The next earnings report is predicted for 2026-08-12 (high confidence).

Earnings reactions

How QNCX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

12

Avg Abs. Movement

±12.77%

Positive %

33.3%

Negative %

66.7%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Feb 12, 2026 ☀ PRE -61.49% open_in_new
Nov 12, 2025 ☽ POST -2.62% open_in_new
Aug 11, 2025 ☽ POST +15.72% open_in_new
May 13, 2025 ☀ PRE -6.86% open_in_new
event

Earnings Count

12

Total earnings in dataset

trending_up

Avg Abs. Movement

±12.77%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 8 →
8
Funds holding
$103203
Total value held
Buying
5 added · 3 reduced
Blackrock, Inc.
$47989 +0.27%
State Street Corp
$25148 +7.55%
Citigroup Inc
$21668 NEW BUY
Northern Trust Corp
$6685 -37.93%
Goldman Sachs Group Inc
$1629 -93.01%

Frequently asked about QNCX earnings

When does Quince Therapeutics, Inc. Common Stock report earnings next? expand_more

Quince Therapeutics, Inc. Common Stock (QNCX)'s next earnings date is predicted (high confidence) for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does QNCX stock move after earnings? expand_more

Over 12 reports, QNCX has moved an average of ±12.77% the session after earnings, closing higher 33.3% of the time.

What was QNCX's biggest post-earnings move? expand_more

QNCX's largest post-earnings gain on record was +18.89% on Nov 13, 2024, and its largest decline was -61.49% on Feb 12, 2026.

Where can I find Quince Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Quince Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.